Overview

Inhaled Treatment for Bronchopulmonary Dysplasia

Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to provide expanded access of S-nitrosylation therapy for the treatment of bronchopulmonary dysplasia
Phase:
Phase 1
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center